Benjamin Jackson CFA
Stock Analyst at Jefferies
(3.04)
# 2,690
Out of 4,707 analysts
91
Total ratings
57.1%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Benjamin Jackson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Maintained: Buy | n/a | $33.53 | - | 2 | Aug 7, 2026 | |
| EPA: IPN Ipsen S.A. | Downgraded: Sell | €117.00 → €135.00 | €159.20 | -15.20% | 3 | Aug 3, 2026 | |
| SWX: CMHC Cosmo N.V. | Maintained: Buy | CHF 140.00 → CHF 110.00 | CHF 55.70 | +97.49% | 3 | Jul 28, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 205.00 | CHF 162.70 | +26.00% | 33 | Jul 23, 2026 | |
| ZLDPF Zealand Pharma A/S | Downgraded: Hold | $79 → $50 | $46.61 | +6.86% | 3 | Jul 13, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,650 → kr 2,800 | kr 2,170 | +29.03% | 2 | Jul 8, 2026 | |
| LON: 0DPB Bavarian Nordic A/S | Maintained: Buy | kr 275.00 → kr 280.00 | kr 210.80 | +32.83% | 2 | May 19, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | CHF 110.00 | CHF 111.80 | -1.61% | 5 | Feb 4, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €100.00 | €74.70 | +33.87% | 9 | Dec 29, 2025 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 415.00 → kr 290.00 | kr 292.00 | -0.68% | 7 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | CHF 270.00 → CHF 230.00 | CHF 350.50 | -34.38% | 6 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,450p | 1,797p | n/a | 2 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 10,900p | 11,876p | n/a | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 | $32.47 | n/a | 1 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €6.80 | €3.16 | n/a | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.8 | $1.82 | n/a | 1 | Oct 7, 2024 |
Genmab
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $33.53
Upside: -
Ipsen S.A.
Aug 3, 2026
Downgraded: Sell
Price Target: €117.00 → €135.00
Current: €159.20
Upside: -15.20%
Cosmo N.V.
Jul 28, 2026
Maintained: Buy
Price Target: CHF 140.00 → CHF 110.00
Current: CHF 55.70
Upside: +97.49%
Galderma Group AG
Jul 23, 2026
Maintained: Buy
Price Target: CHF 205.00
Current: CHF 162.70
Upside: +26.00%
Zealand Pharma A/S
Jul 13, 2026
Downgraded: Hold
Price Target: $79 → $50
Current: $46.61
Upside: +6.86%
Genmab A/S
Jul 8, 2026
Maintained: Buy
Price Target: kr 2,650 → kr 2,800
Current: kr 2,170
Upside: +29.03%
Bavarian Nordic A/S
May 19, 2026
Maintained: Buy
Price Target: kr 275.00 → kr 280.00
Current: kr 210.80
Upside: +32.83%
Novartis AG
Feb 4, 2026
Maintained: Hold
Price Target: CHF 110.00
Current: CHF 111.80
Upside: -1.61%
Sanofi
Dec 29, 2025
Maintained: Buy
Price Target: €100.00
Current: €74.70
Upside: +33.87%
Novo Nordisk A/S
Oct 27, 2025
Maintained: Sell
Price Target: kr 415.00 → kr 290.00
Current: kr 292.00
Upside: -0.68%
Oct 27, 2025
Downgraded: Sell
Price Target: CHF 270.00 → CHF 230.00
Current: CHF 350.50
Upside: -34.38%
Jul 30, 2025
Maintained: Hold
Price Target: 1,450p
Current: 1,797p
Upside: n/a
Jul 29, 2025
Maintained: Hold
Price Target: 10,900p
Current: 11,876p
Upside: n/a
Jan 31, 2025
Upgraded: Buy
Price Target: $29
Current: $32.47
Upside: n/a
Nov 13, 2024
Maintained: Hold
Price Target: €6.80
Current: €3.16
Upside: n/a
Oct 7, 2024
Downgraded: Hold
Price Target: $3.8
Current: $1.82
Upside: n/a